UC, ulcerative colitis

Daclizumab, a humanised monoclonal antibody to the interleukin 2 receptor (CD25), for the treatment of moderately to severely active ulcerative colitis: a randomised, double blind, placebo controlled, dose ranging trial
G Van Assche, W J Sandborn, B G Feagan, B A Salzberg, D Silvers, P S Monroe, W M Pandak, F H Anderson, J F Valentine, G E Wild, D J Geenen, R Sprague, S R Targan, P Rutgeerts, V Vexler, D Young, R S Shames

Gut Nov 2006, 55 (11) 1568-1574; DOI: 10.1136/gut.2005.089854
Threefold increased risk of infertility: a meta-analysis of infertility after ileal pouch anal anastomosis in ulcerative colitis
A Waljee, J Waljee, A M Morris, P D R Higgins

Gut Nov 2006, 55 (11) 1575-1580; DOI: 10.1136/gut.2005.090316
Neutrophil derived human S100A12 (EN-RAGE) is strongly expressed during chronic active inflammatory bowel disease
D Foell, T Kucharzik, M Kraft, T Vogl, C Sorg, W Domschke, J Roth

Gut Jun 2003, 52 (6) 847-853; DOI: 10.1136/gut.52.6.847
Cigarette smoking, appendectomy, and tonsillectomy as risk factors for the development of primary sclerosing cholangitis: a case control study
S A Mitchell, M Thyssen, T R Orchard, D P Jewell, K A Fleming, R W Chapman

Gut Oct 2002, 51 (4) 567-573; DOI: 10.1136/gut.51.4.567

Main menu